| Katherine Elizabeth Cooper, OTR/L, CBIS | |
|
Cmr 402, Apo, AE 09180 | |
| (016) 256-16226 | |
| Not Available |
| Full Name | Katherine Elizabeth Cooper |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 16 Years |
| Location | Cmr 402, Apo, Armed Forces Europe |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750680161 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 06247 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fox Rehabilitation Services Inc | 0143133009 | 898 |
News Archive
The Northeast Assisted Fertility Group (NAFG), already the leading surrogacy and egg donation program in Boston and New York, is pleased to announce the opening of a new office that will expand its services and resources to all its clients in the Atlanta area.
Australian Medical Association (AMA) President, Dr Bill Glasson, said today that Labor's promise to inject another $21 million into anti-smoking awareness campaigns would send a strong message to the community to quit the killer habit.
People with Type 2 diabetes who regained weight forfeited the initial benefits of reduced risk of heart disease or stroke compared to those who maintained their weight loss, according to new research published in the Journal of the American Heart Association, the open access journal of the American Heart Association.
Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration has accepted for priority review the company's new drug application for the potential use of tolvaptan for the treatment of autosomal dominant polycystic kidney disease.
› Verified 2 days ago
| Provider Name | Fox Rehabilitation Services Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1326092503 PECOS PAC ID: 0143133009 Enrollment ID: O20150303000554 |
News Archive
The Northeast Assisted Fertility Group (NAFG), already the leading surrogacy and egg donation program in Boston and New York, is pleased to announce the opening of a new office that will expand its services and resources to all its clients in the Atlanta area.
Australian Medical Association (AMA) President, Dr Bill Glasson, said today that Labor's promise to inject another $21 million into anti-smoking awareness campaigns would send a strong message to the community to quit the killer habit.
People with Type 2 diabetes who regained weight forfeited the initial benefits of reduced risk of heart disease or stroke compared to those who maintained their weight loss, according to new research published in the Journal of the American Heart Association, the open access journal of the American Heart Association.
Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration has accepted for priority review the company's new drug application for the potential use of tolvaptan for the treatment of autosomal dominant polycystic kidney disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katherine Elizabeth Cooper, OTR/L, CBIS Cmr 467 Box 4846, Apo, AE 09096-0049 Ph: (609) 240-6657 | Katherine Elizabeth Cooper, OTR/L, CBIS Cmr 402, Apo, AE 09180 Ph: (016) 256-16226 |
News Archive
The Northeast Assisted Fertility Group (NAFG), already the leading surrogacy and egg donation program in Boston and New York, is pleased to announce the opening of a new office that will expand its services and resources to all its clients in the Atlanta area.
Australian Medical Association (AMA) President, Dr Bill Glasson, said today that Labor's promise to inject another $21 million into anti-smoking awareness campaigns would send a strong message to the community to quit the killer habit.
People with Type 2 diabetes who regained weight forfeited the initial benefits of reduced risk of heart disease or stroke compared to those who maintained their weight loss, according to new research published in the Journal of the American Heart Association, the open access journal of the American Heart Association.
Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration has accepted for priority review the company's new drug application for the potential use of tolvaptan for the treatment of autosomal dominant polycystic kidney disease.
› Verified 2 days ago
Sharon M. Newton, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Cmr 442, Attn Credentials Office, Apo, AE 09042 Phone: 496-221-172274 | |
Arlene C Labeste, M.S. OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Cmr 402, Apo, AE 09180 Phone: 351-966-492155 | |
Stanley T Breuer, OTR/L, CHT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Unit 33100, Apo, AE 09180 Phone: 314-590-7163 | |
Miss Jessica Levy, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center Cmr 402, Apo, AE 09180 Phone: 717-575-5966 | |
Karena Lehman, OTR/L, CHT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Unit 5115, Apo, AE 09461 Phone: 314-226-8561 | |
Jacqueline May Tamayo, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Unit 33100, Apo, AE 09180 Phone: 314-590-4077 | |
Sandra Moore, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Psc 76 Box 263, 65th Med Group/sgh, Apo, AE 09720 Phone: 505-299-2643 |